Title:
【発明の名称】トリアゾール及びテトラゾールの誘導体ならびにその治療上の使用
Document Type and Number:
Japanese Patent JP2002539085
Kind Code:
A
Abstract:
The invention concerns compounds of formula (I) wherein: the pair (A, B) represents (N, N), (N, C) or (C, N); n = 0 if A represents a nitrogen atom, if not, n = 1; m = 0 if B represents a nitrogen atom, if not m = 1; R1 and R2 independently of each other, represent a hydrogen atom, a C1-C6 alkyl, a C2-C6 alkenyl, or a cyclo C3-C6 alkyl group; Ar1 represents a phenyl radical or a pyridyl radical substituted by the groups R3, R'3 and R''3; Ar2 represents a phenyl radical substituted by the groups R4 and R' 4', wherein R3, R'3, R''3, R4 and R'4, independently of one another, represent a hydrogen atom, a halogen atom, a C1-C4 alkyl, hydroxy, a C1-C4 alkoxy, a cyano, a nitro, a perfluoro C1-C2 alkyl, an amino, a C1-C4 alkylamino, a di-(C1-C4 alkyl)-amino, a C1-C4 alkoxycarbonyl amino, a (C1-C4 alkoxycarbonyl) (C1-C4 alkyl)-amino, aminosulphonyl, a C1-C4 alkyl-aminosulphonyl or a di(C1-C4 alkyl)-aminosulphonyl group; and their salts, N-oxides and hydrates. Said compounds have therapeutic applications.
Inventors:
Bertin, Jean
Bovi, Philip, Elle.
Kurtmansh, Jill
Crespan, Olivier
Gerard, Defoss
Fett, ekmal
Bovi, Philip, Elle.
Kurtmansh, Jill
Crespan, Olivier
Gerard, Defoss
Fett, ekmal
Application Number:
JP2000597290A
Publication Date:
November 19, 2002
Filing Date:
January 28, 2000
Export Citation:
Assignee:
SANOFI-SYNTHELABO
International Classes:
A61K31/4439; A61P1/00; A61P1/12; A61P11/00; A61P13/00; A61P13/10; A61P25/28; A61P43/00; C07D249/10; C07D249/12; C07D401/12; C07D401/14; (IPC1-7): C07D401/12; A61K31/4439; A61P1/12; A61P11/00; A61P13/10; A61P25/28; A61P43/00
Attorney, Agent or Firm:
Shintaro Nogawa